27626511|t|Use of bacterial whole-genome sequencing to understand and improve the management of invasive Staphylococcus aureus infections
27626511|a|Management of invasive Staphylococcus aureus infections is complex. Dramatic improvements in bacterial whole genome sequencing (WGS) offer new opportunities for personalising the treatment of S. aureus infections. Areas covered: We address recent achievements in S. aureus genomics, describe genetic determinants of antibiotic resistance and summarise studies that have defined molecular characteristics associated with risk and outcome of S. aureus invasive infections. Potential clinical use of WGS for resistance prediction, infection outcome stratification and management of persisten t / relapsing infections is critically discussed. Expert commentary: WGS is not only providing invaluable information to track the emergence and spread of important S. aureus clones, but also allows rapid determination of resistance genotypes in the clinical environment. An evolving opportunity is to infer clinically important outcomes and optimal therapeutic approaches from widely available S. aureus genome data, with the goal of individualizing management of invasive S. aureus infections.
27626511	7	16	bacterial	T007	UMLS:C0004611
27626511	17	40	whole-genome sequencing	T062	UMLS:C3640076
27626511	71	81	management	T058	UMLS:C0376636
27626511	94	126	Staphylococcus aureus infections	T038	UMLS:C1318973
27626511	127	137	Management	T058	UMLS:C0376636
27626511	150	182	Staphylococcus aureus infections	T038	UMLS:C1318973
27626511	220	229	bacterial	T007	UMLS:C0004611
27626511	230	253	whole genome sequencing	T062	UMLS:C3640076
27626511	255	258	WGS	T062	UMLS:C3640076
27626511	306	315	treatment	T058	UMLS:C0087111
27626511	319	339	S. aureus infections	T038	UMLS:C1318973
27626511	390	399	S. aureus	T007	UMLS:C0038172
27626511	400	408	genomics	T091	UMLS:C0887950
27626511	419	439	genetic determinants	T091	UMLS:C0017400
27626511	547	551	risk	T033	UMLS:C0582147
27626511	556	563	outcome	T033	UMLS:C0243095
27626511	567	576	S. aureus	T007	UMLS:C0038172
27626511	577	596	invasive infections	T038	UMLS:C4285937
27626511	624	627	WGS	T062	UMLS:C3640076
27626511	632	642	resistance	T038	UMLS:C1514892
27626511	655	664	infection	T038	UMLS:C3714514
27626511	673	687	stratification	T170	UMLS:C0008902
27626511	692	702	management	T058	UMLS:C0376636
27626511	706	715	persisten	T038	UMLS:C1264606
27626511	730	740	infections	T038	UMLS:C3714514
27626511	785	788	WGS	T062	UMLS:C3640076
27626511	881	897	S. aureus clones	T007	UMLS:C0038172
27626511	921	934	determination	T058	UMLS:C1148554
27626511	938	948	resistance	T038	UMLS:C1514892
27626511	1024	1053	clinically important outcomes	T033	UMLS:C0243095
27626511	1066	1088	therapeutic approaches	T058	UMLS:C0087111
27626511	1111	1120	S. aureus	T007	UMLS:C0038172
27626511	1121	1127	genome	T017	UMLS:C0017428
27626511	1143	1147	goal	T170	UMLS:C0018017
27626511	1167	1177	management	T058	UMLS:C0376636
27626511	1190	1210	S. aureus infections	T038	UMLS:C1318973